Viable Human SARS-CoV-2 Specific T Cell Transfer in Patients at Risk for Severe COVID-19

Clinical trial NCT04762186 · TERMINATED

Trial details

NCT number: NCT04762186
Sponsor: Universitätsklinikum Köln
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Moderate COVID-19-infection

Start date: 2021-12-08
Primary completion: 2022-08-03
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.